The primary goal of this prospective, exploratory, longitudinal, single-centre, cohort study is to assess the stability of the mitochondrial flux in PBMCs over long-term cryopreservation. Secondary goals of this study are: * to identify changes in the mitochondrial respiratory flux in different metabolic states of cryopreserved PBMCs during long-term cryopreservation. * to assess variability between mitochondrial respiration from PBMCs isolated from same volunteers at different times, seasons or from different arms.
The analysis of mitochondrial function can also be referred to as a bioenergetic snapshot. Mitochondria are dynamic metabolic organelles that adapt to various physiological demands, reflecting an individual's lifestyle and exposure to environmental factors, medications, and toxins. Numerous studies have shown that mitochondrial respiration declines with age and correlates with many age-related diseases. This raises the question of how mitochondria influence cells in a clinical context. For this purpose, 20 participants are recruited and comprehensively characterized in terms of their demographic information and clinical profiles. Additionally, physical examinations are conducted, and participants are surveyed about their lifestyles through questionnaires. Over a 12-month period, blood samples are collected at intervals of three months, resulting in a total of five study visits. For the analysis of mitochondrial oxygen consumption, peripheral blood mononuclear cells (PBMCs) are preferably used, as they provide a minimally invasive and easily accessible insight into mitochondrial function and overall metabolic status and are isolated from the collected blood samples. To enable the application of mitochondrial diagnostics in research for early disease detection and therapeutic development, additional information is needed regarding the stability of mitochondrial respiration in cryopreserved PBMCs using high-resolution respirometry (HRR) with O2k technology. The goal of this study is to assess how the duration of cryopreservation affects mitochondrial bioenergetics compared to freshly isolated PBMCs. The study also considers a variety of parameters that could potentially influence the stability of mitochondrial respiration. These factors include non-fasting blood collection, discrepancies between the right and left arm, and seasonal effects. To what extent the intraindividual variability in these parameters affects the mitochondrial respiration is yet to be fully understood. Furthermore, the longitudinal study design allows the tracking of mitochondrial activity and stability over time, providing a better understanding of the central processes of cellular respiration. Thus, the planned study promises to yield significant insights into mitochondrial respiration and cellular bioenergetics in a clinical context.
Study Type
OBSERVATIONAL
Enrollment
20
Blood drawing
Completion of the questionnaire
Medical University Innsbruck - Department of Neurology
Innsbruck, Tyrol, Austria
Stability of mitochondrial respiratory flux (O2 flux) in cryopreserved PBMCs
Mitochondrial respiratory flux is assessed by High Resolution Respirometry analysis
Time frame: 1 week and every 8 weeks after cryopreservation
Stability of O2 concentration in cryopreserved PBMCs
Mitochondrial respiratory flux is assessed by High Resolution Respirometry analysis
Time frame: 1 week and every 8 weeks after cryopreservation
Assessment of mitochondrial respiratory flux (O2 flux) in fresh PBMCs compared to cryopreserved PBMCs
Mitochondrial respiratory flux is assessed by High Resolution Respirometry analysis
Time frame: Baseline visit, 3, 6, 9, 12 months visit
Assessment of O2 concentration in fresh PBMCs compared to cryopreserved PBMCs
Mitochondrial respiratory flux is assessed by High Resolution Respirometry analysis
Time frame: Baseline visit, 3, 6, 9, 12 months visit
Assessment of O2 flux in fresh and cryopreserved PBMCs in fasted vs non-fasted sampling conditions
Assessement of mitochondrial bioenergetic snapshot in fresh and cryopreserved PBMCs at two different collection time points (fasted and non-fasted)
Time frame: 6 months visit
Assessment of O2 flux in fresh and cryopreserved PBMCs at different seasonal collection time points
Assessement of mitochondrial bioenergetic snapshot in fresh and cryopreserved PBMCs in different seasons
Time frame: Baseline visit, 3, 6, 9, 12 months visit
Assessment of O2 flux in fresh and cryopreserved PBMCs at different venipuncture sites
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Assessement of mitochondrial bioenergetic snapshot in fresh and cryopreserved PBMCs collected from left and right arm
Time frame: 3 months visit
Assessment of blood count and differential blood count I
Analysis of complete blood count (e.g. erythrocyte concentration (mg/dL))
Time frame: Baseline visit, 3, 6, 9, 12 months visit
Assessment of blood count and differential blood count II
Analysis of complete blood count (e.g. haemoglobin concentration (g/dL))
Time frame: Baseline visit, 3, 6, 9, 12 months visit
Concentration of Creatinine and Urea
Creatinine (mg/dL), Urea (mg/dL)
Time frame: Baseline visit, 3, 6, 9, 12 months visit
Concentration of Creatine Kinase
Creatine Kinase (U/L)
Time frame: Baseline, 6, 12 months visit
Concentration of Glucose
Glucose (mg/dL, mmol/L)
Time frame: Baseline visit, 3, 6, 9, 12 months visit
Concentration of HbA1c
HbA1c (%)
Time frame: Baseline, 6, 12 months visit
Concentration of Sodium, Potassium, Chloride and Calcium
Sodium (mmol/L), potassium (mmol/L), chloride (mmol/L), calcium (mmol/L)
Time frame: Baseline, 6, 12 months visit
Concentration of GOT and GPT
Glutamic-oxaloacetic transaminase (GOT, U/L), glutamic-pyruvic transaminase (GPT, U/L), gamma-glutamyl-transpeptidase (gamma-GT, U/L), lactate dehydrogenase (LDH, U/L)
Time frame: Baseline, 6, 12 months visit
Concentration of triglyceride and cholesterol
Triglyceride (mmol/L), cholesterol (all, mmol/L )
Time frame: Baseline, 6, 12 months visit
Concentration of LDL-cholesterol and HDL-cholesterol
LDL-cholesterol (mg/dL), HDL-cholesterol (mg/dL)
Time frame: Baseline, 6, 12 months visit
Concentration of Lipoprotein a
Lipoprotein a (mg/dL)
Time frame: Baseline visit
Assessment of Sedimentation rate
Sedimentation rate (mm/h)
Time frame: Baseline, 12 months visit
Concentration of C-reactive protein
CRP sensitive (mg/L)
Time frame: Baseline visit, 3, 6, 9, 12 months visit
Concentration of Interleukin-6
Interleukin-6 (pg/ml)
Time frame: Baseline, 6, 12 months visit
Concentration of Thyroid-stimulating hormone
TSH (mU/mL)
Time frame: Baseline, 12 months visit
Concentration of Iric acid
Uric acid (mg/dL)
Time frame: Baseline, 12 months visit
Concentration of Ferritin
Ferritin (ng/mL, μg/L)
Time frame: Baseline, 12 months visit